ESR1 and neoplasm: Tumor gene expression profiles (NKI-147) were processed in the same fashion as the sorted cell lines and tumor profiles were compared to the ESR1, GATA3, and c-Myb gene signatures to demonstrate which breast tumor subtypes were enriched for these signatures (Fig. 4, left).